WallStreetZenWallStreetZen

NYSE: LH
Laboratory Corp Of America Holdings Earnings & Revenue

Open Broker Account

LH past earnings growth

How has LH's earnings growth performed historically?
Company
-28.67%
Industry
13.62%
Market
53.18%
LH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
LH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
LH's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

LH past revenue growth

How has LH's revenue growth performed historically?
Company
-4.11%
Industry
16.11%
Market
113.02%
LH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LH's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LH earnings and revenue history

Current Revenue
$15.7B
Current Earnings
$2.0B
Current Profit Margin
12.7%
LH's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

LH Return on Equity

Current Company
19%
Current Industry
46.5%
Current Market
25.7%
LH's Return on Equity (19%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LH announces earnings.

LH Return on Assets

Current Company
9.7%
Current Industry
7.9%
LH is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LH Return on Capital Employed

Current Company
15.42%
Current Industry
13.7%
LH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LH vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LH$15.72B$3.63B$1.99B+10.14%+24.98%
WAT$2.90B$992.24M$702.12M+5.57%+11.52%
PKI$5.02B$1.49B$674.10M+18.57%+10.11%
ICLR$7.59B$1.06B$209.90M+34.59%-11.86%
DGX$10.58B$2.51B$1.48B+8.23%+19.35%

LH earnings dates

Next earnings date
Oct 26, 2022

Laboratory Of America Holdings Earnings & Revenue FAQ

What were LH's earnings last quarter?

On Invalid Date, Laboratory Of America Holdings (NYSE: LH) reported Q2 2022 earnings per share (EPS) of $3.89, up 18.96% year over year. Total Laboratory Of America Holdings earnings for the quarter were $358.60 million. In the same quarter last year, Laboratory Of America Holdings's earnings per share (EPS) was $4.80.

If you're new to stock investing, here's how to buy Laboratory Of America Holdings stock.

What was LH's earnings growth in the past year?

As of Q4 2022, Laboratory Of America Holdings's earnings has grown -28.67% year over year. This is 42.3 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 13.62%. Laboratory Of America Holdings's earnings in the past year totalled $1.99 billion.

What is LH's earnings date?

Laboratory Of America Holdings's earnings date is Invalid Date. Add LH to your watchlist to be reminded of LH's next earnings announcement.

What was LH's revenue last quarter?

On Invalid Date, Laboratory Of America Holdings (NYSE: LH) reported Q2 2022 revenue of $3.70 billion up 3.74% year over year. In the same quarter last year, Laboratory Of America Holdings's revenue was $3.84 billion.

What was LH's revenue growth in the past year?

As of Q4 2022, Laboratory Of America Holdings's revenue has grown -4.11% year over year. This is 20.22 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 16.11%. Laboratory Of America Holdings's revenue in the past year totalled $15.72 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.